Lipase

Cat.No. Product Name Information Product Use Citations Product Validations
S1629 Orlistat Orlistat is a general lipase inhibitor with IC50 of 122 ng/ml for PL from human duodenal juice. This compound treatment reduces proliferation, induces apoptosis and arrests cell cycle.
Cell Rep, 2025, 44(7):115901
Acta Pharmacol Sin, 2025, 10.1038/s41401-025-01477-y
J Cell Sci, 2024, 137(20)jcs262162
S4904 JZL184 JZL 184 is the first selective inhibitor of monoacylglycerol lipase (MAGL) with IC50 of 8 nM.
Nat Chem Biol, 2022, 10.1038/s41589-022-00996-7
Biomed Pharmacother, 2022, 149:112798
J Cardiovasc Transl Res, 2022, 10.1007/s12265-022-10323-z
S7364 Atglistatin Atglistatin is a highly potent, and selective inhibitor of adipose triglyceride lipase (ATGL) with IC50 of 0.7 μM, high selectivity over other key metabolic lipases.
Nat Commun, 2025, 16(1):4432
Int J Nanomedicine, 2025, 20:9019-9030
J Cell Mol Med, 2025, 29(14):e70693
Verified customer review of Atglistatin
S9404 Pristimerin Pristimerin is a naturally occurring triterpenoid that has been shown to suppress the proliferation of various cancer cell lines at the concentration (IC50) range of 0.2-4 μM, including those of breast, glioma, prostate, pancreatic, ovarian, colon. This compound can inhibit monoacylglycerol lipase(MGL) with an IC50 of 93 nM through a reversible mechanism.
Cell Death Dis, 2020, 14;11(4):232
S7457 XEN445 XEN445 is a potent and selective endothelial lipase inhibitor with IC50 of 0.237 μM.
S7543 JW642 JW642 is a potent inhibitor of monoacylglycerol lipase (MAGL) that displays IC50 values of 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively.
S9234 Schaftoside Schaftoside, a bioactive compound found in the Herba Desmodii Styracifolii, exhibits pancreatic lipase inhibitory activity. This compound inhibits the expression of TLR4 and Myd88. It also decreases Drp1 expression and phosphorylation, and reduces mitochondrial fission.
S0536 Ibrolipim Ibrolipim (NO-1886) is an effective lipoprotein lipase (LPL) activator that increases LPL mRNA and LPL activity in adipose tissue, myocardium, and skeletal muscle.
S4825 Pancreatin Pancreatin (Pancrelipase, Pancreatic enzymes), are commercial mixtures of amylase, lipase, and protease. They are used to treat malabsorption syndrome due to pancreatic problems.(PROTEASE ACTIVITY ≥ 275 USP.u/mg;Amvlase activity ≥ 275 USP.u/mg;Lipase Activity ≥ 22 USP.u/mg)
S6550 URB602 URB602 is an inhibitor of monoacylglycerol lipase (MGL), a serine hydrolase involved in the biological deactivation of the endocannabinoid 2-arachidonoyl-sn-glycerol (2-AG).